Mayo Clinic Proceedings

Rose, Steven H.; Curry, Timothy B.
November 2009
Mayo Clinic Proceedings;Nov2009, Vol. 84 Issue 11, p955
Academic Journal
The authors offer insights on the article by Charles A. Czeisler and colleagues highlighting the efficacy of armodafinil for the treatment of excessive sleepiness associated with shift work disorder. They stresses concern on the effects of fatigue on resident physician's clinical performance, as well as the duty assignments' impact on resident learning. Moreover, they contend that even if armodafinil drugs are thought to be safe and effective, these drugs may have unintended effects.


Related Articles

  • Modafinil.  // Reactions Weekly;11/15/2008, Issue 1228, p27 

    The article describes the case of a 48-year-old man, who had chronic paranoid schizophrenia. The man has been receiving clozapine and started receiving modafinil 100 milligrams twice daily for drowsiness. The drug's side effects after 48 hours included abrupt behavioural changes, altered thought...

  • Modafinil.  // AHFS Consumer Medication Information;Oct2017, p1 

    Modafinil is used to treat excessive sleepiness caused by narcolepsy (a condition that causes excessive daytime sleepiness) or shift work sleep disorder (sleepiness during scheduled waking hours and difficulty falling asleep or staying asleep during scheduled sleeping hours in people who work at...

  • Armodafinil.  // Reactions Weekly;Feb2015, Vol. 1539 Issue 1, p49 

    The article describes the case of acute hepatitis that developed in an 18-year-old boy during treatment with armodafinil for narcolepsy.

  • Scientific Judgment. Shiffman, Melvin A. // International Journal of Cosmetic Surgery & Aesthetic Dermatolog;Dec2000, Vol. 2 Issue 4, p269 

    Focuses on the scientific judgment of physicians on medications and procedures. Awareness of physicians on the severe side effects of drugs on the market; Petition to ban the use of the chemical dihydrogen monoxide; Importance of informing patients on the procedure as experimental.

  • What You Don't Know Can Hurt You.  // People's Medical Society Newsletter;Jun2001, Vol. 20 Issue 3, p7 

    Discusses a survey which examined whether patients believe that physicians should use discretion in giving information about the side effects of the medication they prescribe.

  • Death of the silent witness. Iheanacho, Ike // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/2/2011, Vol. 343 Issue 7813, p48 

    The article presents the author's view on the development of direct patient reporting. The author states that patient must have the power to notify directly drug regulators about suspected unwanted effects. The author mentions that the raw information on the unwanted effects is sifted by...

  • Drug-induced diseases. Critchley, E.M.R. // British Medical Journal;3/31/1979, Vol. 1 Issue 6167, p862 

    Presents a discussion on drug-induced neurological diseases. Inevitability of side effects from modern drugs; Improvement of expertise of doctors in applied therapeutics; Hazards of the benzodiazepines.

  • You and Your Doctor: The Drug Dialogue. Dunkin, Mary Anne // Arthritis Today;Jul/Aug99, Vol. 13 Issue 4, p46 

    Gives suggestions to promote important drug dialogue between patient and doctor or pharmacist. What to do if side effects occur; How long should a patient wait for the drug to work; Advice for patient who misses a dose.

  • The power of suggestion doesn't induce drug side effects.  // Modern Medicine;Apr95, Vol. 63 Issue 4, p37 

    Presents an abstract of the study `Can physicians warn patients of potential side effects without fear of causing those side effects?' by G.C. Lamb et al from the December 12, 1995 issue of the journal `Archives of Internal Medicine.'


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics